期刊
TOXICOLOGY IN VITRO
卷 25, 期 1, 页码 21-27出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.tiv.2010.09.001
关键词
Cytochrome P450; Herbal drugs; Silybum marianum; Drug-drug interaction
类别
资金
- Pascoe GmbH, Giessen, Germany
- Pascoe pharmazeutische Praparate GmbH, Giessen, Germany
The effect of a standardised dry extract from Silybum marianum (HEPAR-PASC (R)) on the enzyme kinetics of cytochrome-P450 isoenzymes (CYP) was investigated with primary human hepatocytes and human liver microsomes in order to assess the potential for drug-drug interactions. A cytotoxic effect on hepatocytes was observed at concentrations at and above 50 mu g/ml. The EC(50) value was calculated to be 72.0 mu g/ml. Therefore, the chosen test concentrations for CYP induction on human hepatocytes were 50, 10, and 1.5 mu g/ml, which allowed for interpretation of the clinical significance of the data with a range of 50-1-fold c(max) at maximal recommended doses. No induction was observed at the lowest concentration of 1.5 mu g/ml, which is close to c(max). The extract did not induce CYP 3A4 at any of the tested concentrations. A low or marginal induction of 1A2, 286, and 2E1 at the maximum concentration of 50 mu g/ml was observed. CYP inhibition on human microsomes was tested at concentrations of 150, 15, and 1.5 mu g/ml. No or minor CYP inhibition was observed for all CYPs tested at the lowest concentration of 1.5 mu g/ml, i.e. CYPs 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4. At concentrations of 15 and 150 mu g/ml the extract significantly inhibited CYP 2B6, 2C8, 2C9, 2C19, 2E1, and 3A4. In these cases. K(i) values were determined. All K(i) values exceeded c(max) by at least a factor of 10-fold. According to FDA regulations 1 > c(max)/K(i) > 0.1 indicates, that drug-drug interactions are possible for CYPs 2C8, and 2C9, but not likely, and are remote for CYPs 2C19, 2D6, and 3A4. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据